Actinium Pharmaceuticals, Inc.
AMEX:ATNM
4.49 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.081 | 1.03 | 1.144 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.699 | 0.524 | 0.447 | 0.42 | 0.051 | 0.056 | 0.078 | 0.053 | 0 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0.081 | 0.331 | 0.62 | -0.447 | -0.42 | -0.051 | -0.056 | -0.078 | -0.053 | 0 | -0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 1 | 0.321 | 0.542 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 30.045 | 38.67 | 23.135 | 18.031 | 16.085 | 16.55 | 17.095 | 17.7 | 17.501 | 13.312 | 12.267 | 2.667 | 3.44 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.076 | 13.331 | 11.999 | 8.077 | 6.308 | 5.522 | 6.733 | 9.155 | 9.269 | 11.465 | 10.175 | 3.919 | 4.506 | 0.01 | 0.025 | 0.015 | 0.019 | 0.011 | 0.018 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.076 | 13.331 | 11.999 | 8.077 | 6.308 | 5.522 | 6.733 | 9.155 | 9.269 | 11.465 | 10.175 | 3.919 | 4.506 | 0.01 | 0.025 | 0.015 | 0.019 | 0.011 | 0.018 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.056 | 0.078 | 0.053 | 0.038 | 0.002 | 0.001 | 0 | 0 | 0 | 0 | 0.001 | 0 |
| Operating Expenses
| 42.121 | 52.001 | 35.134 | 26.108 | 22.393 | 22.071 | 23.827 | 26.911 | 26.847 | 24.83 | 22.481 | 6.588 | 7.947 | 0.01 | 0.025 | 0.015 | 0.026 | 0.012 | 0.018 |
| Operating Income
| -42.121 | -51.92 | -34.104 | -24.964 | -22.393 | -22.071 | -23.827 | -26.911 | -26.847 | -24.83 | -22.481 | -6.592 | -7.947 | -0.01 | -0.026 | -0.016 | -0.026 | -0.012 | -0.018 |
| Operating Income Ratio
| 0 | -640.988 | -33.111 | -21.822 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.878 | 3.102 | 1.087 | 0.19 | 0.178 | 0.172 | 0.173 | 0.31 | 2.526 | 3.804 | -2.207 | -4.182 | -0.414 | 0.02 | 0.028 | -0.006 | -0.005 | 0 | 0 |
| Income Before Tax
| -38.243 | -48.818 | -33.017 | -24.774 | -22.215 | -21.899 | -23.654 | -26.601 | -24.322 | -21.025 | -24.688 | -10.774 | -8.361 | 0.01 | 0.002 | -0.022 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0 | -602.691 | -32.055 | -21.656 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -1.087 | -0.19 | -0.178 | -0.172 | 0.173 | -0.31 | 0.005 | 0.008 | 0.001 | 0.003 | 1.099 | 0.004 | 0.006 | 0.005 | 0.031 | 0.015 | 0.018 |
| Net Income
| -38.243 | -48.818 | -31.93 | -24.584 | -22.037 | -21.727 | -23.654 | -26.601 | -24.322 | -21.025 | -24.688 | -10.774 | -8.361 | 0.01 | 0.002 | -0.022 | -0.031 | -0.015 | -0.018 |
| Net Income Ratio
| 0 | -602.691 | -31 | -21.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.27 | -1.83 | -1.32 | -1.2 | -1.82 | -4.37 | -6.69 | -11.96 | -15.06 | -16.53 | -27.07 | -14.21 | -227.31 | 0.38 | 0.005 | -0.06 | -0.084 | -0.04 | -0.24 |
| EPS Diluted
| -1.27 | -1.83 | -1.32 | -1.2 | -1.82 | -4.37 | -6.69 | -11.96 | -15.06 | -16.53 | -27.07 | -14.21 | -227.31 | 0.38 | 0.005 | -0.06 | -0.084 | -0.04 | -0.24 |
| EBITDA
| -37.432 | -51.13 | -33.405 | -24.44 | -21.768 | -21.479 | -23.777 | -26.855 | -26.77 | -24.776 | -22.443 | -6.586 | -7.947 | 0.015 | 0.008 | -0.015 | -0.026 | -0.012 | -0.018 |
| EBITDA Ratio
| 0 | -631.235 | -32.432 | -21.364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |